New heart pump device aims to support patients during risky procedures
NCT ID NCT06565039
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test the safety and effectiveness of the Supira System, a temporary heart pump, in patients undergoing high-risk coronary interventions. The device is inserted through a leg artery to help pump blood from the heart to the body during the procedure. However, the trial was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Supira System (temporary heart pump device)
- What this could lead to
- If successful, this device could provide a safer way to support the heart during high-risk procedures, potentially reducing complications.
- What could go wrong
- This trial was withdrawn before enrolling any participants, so no data is available. The device is still early in testing, and its safety and effectiveness are unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.